ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 327 filers reported holding ROYALTY PHARMA PLC in Q1 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $294,115 | -96.2% | 10,837 | -95.7% | 0.00% | -97.0% |
| Q2 2023 | $7,668,922 | +317.2% | 249,477 | +389.0% | 0.07% | +266.7% |
| Q1 2023 | $1,838,069 | -78.2% | 51,015 | -76.1% | 0.02% | -74.3% |
| Q4 2022 | $8,427,126 | +862.0% | 213,237 | +878.2% | 0.07% | +900.0% |
| Q3 2022 | $876,000 | -19.8% | 21,800 | -16.0% | 0.01% | -36.4% |
| Q2 2022 | $1,092,000 | -63.2% | 25,967 | -65.9% | 0.01% | -59.3% |
| Q1 2022 | $2,971,000 | +21.6% | 76,254 | +24.4% | 0.03% | +22.7% |
| Q4 2021 | $2,443,000 | +574.9% | 61,290 | +593.1% | 0.02% | +450.0% |
| Q2 2021 | $362,000 | -92.2% | 8,843 | -91.7% | 0.00% | -92.9% |
| Q1 2021 | $4,627,000 | +269.9% | 106,080 | +324.3% | 0.06% | +229.4% |
| Q4 2020 | $1,251,000 | -8.3% | 25,000 | -22.9% | 0.02% | -34.6% |
| Q3 2020 | $1,364,000 | – | 32,418 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Siguler Guff Advisers, LLC | 3,391,754 | $122,204,897 | 47.65% |
| Vantage Consulting Group Inc | 1,022,194 | $36,829,650 | 20.91% |
| Indie Asset Partners, LLC | 433,000 | $15,600,990 | 18.22% |
| Overbrook Management Corp | 578,783 | $20,853,551 | 5.46% |
| Silicon Valley Community Foundation | 1,032,320 | $37,194,490 | 5.36% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,047,049 | $109,785,175 | 4.64% |
| Geo Capital Gestora de Recursos Ltd | 142,748 | $5,143 | 3.81% |
| Renaissance Capital LLC | 123,913 | $4,464,585 | 3.31% |
| Rokos Capital Management LLP | 1,106,813 | $40,077,698 | 2.96% |
| Lagoda Investment Management, L.P. | 101,500 | $3,657,045 | 2.60% |